Caplin Point Laboratories informs about press release

08 Mar 2023 Evaluate

Caplin Point Laboratories has informed that it enclosed Press Release regarding grant of USFDA approval for Abbreviated New Drug Application (ANDA) Thiamine Hydrochloride Injection USP, to its Subsidiary Caplin Steriles.

The above information is a part of company’s filings submitted to BSE.

Caplin Point Lab Share Price

1721.50 -13.25 (-0.76%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×